Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine
The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. F...
Saved in:
Published in | Journal of Neural Transmission Vol. 113; no. 1; pp. 1 - 10 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Austria
Springer Nature B.V
01.01.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. Furthermore, blockade of NMDA receptors might lead to an inhibition of NO-synthesis, and, accordingly, both of these effects might influence sensitization phenomena in a similar way. Male Wistar rats were sensitized to morphine by administrations of 3 mg/kg of morphine i.p. on day 1, 3, 5, and 7 and saline on days 2, 4, and 6. In part of the animals, the administration of morphine was performed in association with conditional stimuli, CS (test cage plus an auditory and an olfactory stimulus), in the other part not (pseudoconditioned, PCS). On day 17, the sensitization was more pronounced in the CS than the PCS group. The effects of dizocilpine (MK-801; 0.1 mg/kg i.p.), a blocker of NMDA glutamate receptors, or of L-NAME (N(G)-nitro-L-arginine methylester; 10 mg/kg i.p.), a non-specific inhibitor of NO synthase and the effect of N(omega)-propyl-L-arginine (20 mg/kg i.p.), a specific inhibitor of neuronal NO synthase, on expression or development of sensitization to morphine was studied. Neither MK-801 nor L-NAME influenced the development of associative and non-associative behavioural sensitization to morphine. The expression of sensitization to morphine was not influenced by MK-801. L-NAME inhibited the expression of associative, but not of non-associative sensitization. Surprisingly, inhibition of neuronal NO synthase, did not influence the expression of associative sensitization. We suggest that NMDA receptors were not involved in development or expression of both types of sensitization. Furthermore, the manifestation of the associative, but not the non-associative sensitization to morphine appeared to be dependent on a type of NO synthase, which is not the neuronal NO synthase, but probably the inducible NOS. |
---|---|
AbstractList | The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. Furthermore, blockade of NMDA receptors might lead to an inhibition of NO-synthesis, and, accordingly, both of these effects might influence sensitization phenomena in a similar way. Male Wistar rats were sensitized to morphine by administrations of 3 mg/kg of morphine i.p. on day 1, 3, 5, and 7 and saline on days 2, 4, and 6. In part of the animals, the administration of morphine was performed in association with conditional stimuli, CS (test cage plus an auditory and an olfactory stimulus), in the other part not (pseudoconditioned, PCS). On day 17, the sensitization was more pronounced in the CS than the PCS group. The effects of dizocilpine (MK-801; 0.1 mg/kg i.p.), a blocker of NMDA glutamate receptors, or of L-NAME (N(G)-nitro-L-arginine methylester; 10 mg/kg i.p.), a non-specific inhibitor of NO synthase and the effect of N(omega)-propyl-L-arginine (20 mg/kg i.p.), a specific inhibitor of neuronal NO synthase, on expression or development of sensitization to morphine was studied. Neither MK-801 nor L-NAME influenced the development of associative and non-associative behavioural sensitization to morphine. The expression of sensitization to morphine was not influenced by MK-801. L-NAME inhibited the expression of associative, but not of non-associative sensitization. Surprisingly, inhibition of neuronal NO synthase, did not influence the expression of associative sensitization. We suggest that NMDA receptors were not involved in development or expression of both types of sensitization. Furthermore, the manifestation of the associative, but not the non-associative sensitization to morphine appeared to be dependent on a type of NO synthase, which is not the neuronal NO synthase, but probably the inducible NOS. The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. Furthermore, blockade of NMDA receptors might lead to an inhibition of NO-synthesis, and, accordingly, both of these effects might influence sensitization phenomena in a similar way. Male Wistar rats were sensitized to morphine by administrations of 3 mg/kg of morphine i.p. on day 1, 3, 5, and 7 and saline on days 2, 4, and 6. In part of the animals, the administration of morphine was performed in association with conditional stimuli, CS (test cage plus an auditory and an olfactory stimulus), in the other part not (pseudoconditioned, PCS). On day 17, the sensitization was more pronounced in the CS than the PCS group. The effects of dizocilpine (MK-801; 0.1 mg/kg i.p.), a blocker of NMDA glutamate receptors, or of L-NAME (N(G)-nitro-L-arginine methylester; 10 mg/kg i.p.), a non-specific inhibitor of NO synthase and the effect of N(ω)-propyl-L-arginine (20 mg/kg i.p.), a specific inhibitor of neuronal NO synthase, on expression or development of sensitization to morphine was studied. Neither MK-801 nor L-NAME influenced the development of associative and non-associative behavioural sensitization to morphine. The expression of sensitization to morphine was not influenced by MK-801. L-NAME inhibited the expression of associative, but not of non-associative sensitization. Surprisingly, inhibition of neuronal NO synthase, did not influence the expression of associative sensitization. We suggest that NMDA receptors were not involved in development or expression of both types of sensitization. Furthermore, the manifestation of the associative, but not the non-associative sensitization to morphine appeared to be dependent on a type of NO synthase, which is not the neuronal NO synthase, but probably the inducible NOS. |
Author | Kuschinsky, K Atalla, A |
Author_xml | – sequence: 1 givenname: A surname: Atalla fullname: Atalla, A organization: Institute of Pharmacology and Toxicology, Faculty of Pharmacy, University of Marburg, Marburg, Germany – sequence: 2 givenname: K surname: Kuschinsky fullname: Kuschinsky, K |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15843868$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URKeFB2CDLBbsAtd2HCfLqpQWqT-bdm059g2TksTBdiqGR-PpcDQjgdjUC_8cf-faV-eEHE1-QkLeMvjIANSnmCfgBYAsgDd1AS_IhpVCFqysxBHZgAAoGlmVx-QkxkcAYEzVr8gxk3Up6qrekN8XXYc2Reo72g7efjcO1_23YUlmNAnp7c3nMxrQ4px8yFxYr2_vaNxNaWtipieatkgdPuHg5xGntEKrhD_ngDH2mcgeE6O3vUn9E65A7qX4V4o4xT71v_Jprehp_o0ffX6UGpuJvd7u6OjDvO0nfE1edmaI-OawnpKHLxf351fF9d3l1_Oz68IKqVLRKoFgVAd11bZllUfrmOTYuAawrMDYTrm2EaypWu6UdRYdF7VtFK94hyhOyYd93Tn4HwvGpMc-WhwGM6Ffoq6UrGuu5LMga7hSvCwz-P4_8NEvYcpNaJ4DEg2TK8T2kA0-xoCdnkM_mrDTDPQav97Hr3P8eo1fQ_a8OxRe2hHdX8chb_EHMaCxIA |
CODEN | JNTRF3 |
CitedBy_id | crossref_primary_10_1007_s00213_011_2354_9 crossref_primary_10_1016_j_biopsych_2013_04_026 crossref_primary_10_1016_j_pnpbp_2014_11_004 crossref_primary_10_1111_j_1471_4159_2007_04811_x crossref_primary_10_1016_j_bbr_2009_09_016 crossref_primary_10_1016_j_ejphar_2010_11_037 crossref_primary_10_1016_j_ejphar_2006_11_067 crossref_primary_10_1016_j_yebeh_2010_12_020 crossref_primary_10_1002_syn_21503 crossref_primary_10_1016_j_neulet_2009_08_017 crossref_primary_10_1007_s00213_007_0984_8 crossref_primary_10_1111_1440_1681_13779 crossref_primary_10_1016_j_ejphar_2020_173274 crossref_primary_10_1007_s00213_009_1687_0 crossref_primary_10_1016_j_ejphar_2006_10_044 crossref_primary_10_1007_s11064_010_0325_x crossref_primary_10_1016_j_brainres_2009_06_100 crossref_primary_10_1111_jnc_14952 crossref_primary_10_1002_syn_20440 |
Cites_doi | 10.1007/s00702-002-0791-7 10.1016/j.ejphar.2004.09.042 10.1002/syn.890140307 10.1007/s002130000493 10.1016/0197-0186(82)90055-9 10.1007/s002130000447 10.1016/0006-8993(89)91140-2 10.1002/syn.890160207 10.1016/S0306-4522(01)00483-3 10.1523/JNEUROSCI.14-12-07415.1994 10.1016/S0014-2999(02)02696-1 10.1016/0024-3205(81)90157-0 10.1007/s002100000287 10.1002/syn.10076 10.1016/j.ejphar.2003.10.006 10.1016/S0031-9384(01)00588-1 10.1016/S0014-2999(02)02038-1 10.1016/S0301-0082(97)00090-7 10.1016/0028-3908(75)90129-X 10.1007/PL00004979 10.1007/s00210-003-0855-8 10.1016/0306-4522(96)00313-2 10.1002/syn.890050104 |
ContentType | Journal Article |
Copyright | Springer-Verlag/Wien 2006 |
Copyright_xml | – notice: Springer-Verlag/Wien 2006 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. 7TK 7X8 |
DOI | 10.1007/s00702-005-0298-0 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1435-1463 |
EndPage | 10 |
ExternalDocumentID | 947457631 10_1007_s00702_005_0298_0 15843868 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | -53 -BR 1SB 28- 29L 29~ 3SX 40D 40E 5QI 5RE 95- 95. 95~ ABMNI AEFIE AGWIL ALMA_UNASSIGNED_HOLDINGS BBWZM CGR CUY CVF ECM EIF F5P LAS NPM O93 O9G O9I O9J P19 QOK RHV RNI ROL RZK SDE SOJ WK6 ~EX AAYXX CITATION --- -5E -Y2 .86 06D 0R~ 0VY 1N0 203 30V 36B 4.4 53G 5VS 6NX 78A AAAVM AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AAYIU AAYQN ABAKF ABDZT ABECU ABFTV ABHLI ABIVO ABJOX ABKCH ABKTR ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHXU ACIPQ ACKNC ACMDZ ACMLO ACOKC ACZOJ ADHHG ADHIR ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGXH AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AFLOW AFWTZ AFYQB AFZKB AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHIZS AHKAY AHMBA AHSBF AIAGR AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJZVZ AKMHD ALWAN AMKLP AMTXH AMXSW AMYQR AOCGG ARMRJ AXYYD AZFZN BDATZ BGNMA CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EPAXT ESBYG FERAY FFXSO FIGPU FINBP FRRFC FSGXE FWDCC GGCAI GGRSB GJIRD GNWQR H13 HF~ HG5 HMJXF HQYDN HRMNR HZ~ I09 IHE IKXTQ IWAJR IZIGR IZQ I~X J0Z JBSCW JCJTX JZLTJ K9. LLZTM M4Y N2Q N9A NPVJJ NQJWS NU0 O9- OVD P2P PQQKQ PT4 PT5 R9I RPX SCLPG SDM SISQX SJYHP SNPRN SOHCF SPISZ SRMVM SSLCW SSXJD SV3 TEORI TSK TSV TT1 UG4 UOJIU UTJUX UZXMN VFIZW WJK WK8 YLTOR Z7U Z82 Z83 Z87 Z8O Z8V Z8W Z91 ZMTXR ZOVNA 7TK 7X8 |
ID | FETCH-LOGICAL-c357t-b73e0a7f086bb46666bd152e9d90e460acf7db93196b2d7cdced238c97262fee3 |
ISSN | 0300-9564 |
IngestDate | Sat Oct 26 00:43:18 EDT 2024 Fri Oct 25 05:20:21 EDT 2024 Thu Oct 10 18:01:06 EDT 2024 Fri Aug 23 04:06:15 EDT 2024 Sat Sep 28 07:45:35 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c357t-b73e0a7f086bb46666bd152e9d90e460acf7db93196b2d7cdced238c97262fee3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 15843868 |
PQID | 217839154 |
PQPubID | 51646 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_67588275 proquest_miscellaneous_19277244 proquest_journals_217839154 crossref_primary_10_1007_s00702_005_0298_0 pubmed_primary_15843868 |
PublicationCentury | 2000 |
PublicationDate | 2006-Jan 2006-1-00 20060101 |
PublicationDateYYYYMMDD | 2006-01-01 |
PublicationDate_xml | – month: 01 year: 2006 text: 2006-Jan |
PublicationDecade | 2000 |
PublicationPlace | Austria |
PublicationPlace_xml | – name: Austria – name: Wien |
PublicationTitle | Journal of Neural Transmission |
PublicationTitleAlternate | J Neural Transm (Vienna) |
PublicationYear | 2006 |
Publisher | Springer Nature B.V |
Publisher_xml | – name: Springer Nature B.V |
References | 20487869 - Neurochem Int. 1982;4(4):199-215 15496304 - Eur J Pharmacol. 2004 Oct 25;503(1-3):103-7 1237099 - Neuropharmacology. 1975 Aug;14(8):611-4 7194958 - Life Sci. 1981 Feb 16;28(7):755-60 10997725 - Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):232-7 8211708 - Synapse. 1993 Jul;14(3):243-5 9109371 - Naunyn Schmiedebergs Arch Pharmacol. 1997 Apr;355(4):531-7 2679971 - Brain Res. 1989 Oct 9;499(1):108-20 12658363 - J Neural Transm (Vienna). 2003 Apr;110(4):353-62 8197575 - Synapse. 1994 Feb;16(2):137-47 7527843 - J Neurosci. 1994 Dec;14(12):7415-25 8951881 - Neuroscience. 1996 Dec;75(3):881-90 9560846 - Prog Neurobiol. 1998 Apr;54(6):679-720 12498915 - Eur J Pharmacol. 2003 Jan 1;458(1-2):119-28 11984858 - Synapse. 2002 Jun 15;44(4):227-45 11790403 - Physiol Behav. 2001 Nov-Dec;74(4-5):441-7 14673514 - Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):228-31 11801363 - Neuroscience. 2002;109(2):267-74 2300906 - Synapse. 1990;5(1):48-58 12167469 - Eur J Pharmacol. 2002 Aug 9;449(3):269-77 10972458 - Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120 10972474 - Psychopharmacology (Berl). 2000 Aug;151(2-3):273-82 11224409 - Behav Pharmacol. 1996 Mar;7(2):169-184 14660024 - Eur J Pharmacol. 2003 Dec 15;482(1-3):205-13 MR Zarrindast (298_CR25) 2003; 482 I Afanas’ev (298_CR1) 2000; 362 A Badiani (298_CR3) 2000; 151 R Spanagel (298_CR19) 1993; 14 A Gholami (298_CR5) 2002; 449 ME Wolf (298_CR24) 1998; 54 U Havemann (298_CR9) 1982; 4 AR West (298_CR23) 2002; 44 TM Tzschentke (298_CR20) 1996; 7 RM Post (298_CR16) 1981; 28 S Scheggi (298_CR17) 2002; 109 A-K Lienau (298_CR13) 1997; 355 K Park (298_CR14) 2001; 74 DM Bannerman (298_CR4) 1994; 14 298_CR15 MT Silva (298_CR18) 2003; 110 A Gholami (298_CR6) 2003; 458 LJMJ Vanderschuren (298_CR21) 2000; 151 P Vezina (298_CR22) 1989; 499 M Jeziorski (298_CR10) 1994; 16 H Hara (298_CR8) 1996; 75 D Klamer (298_CR12) 2004; 503 M Babbini (298_CR2) 1975; 14 PW Kalivas (298_CR11) 1990; 5 M Grönig (298_CR7) 2004; 369 |
References_xml | – volume: 110 start-page: 353 year: 2003 ident: 298_CR18 publication-title: J Neural Transm doi: 10.1007/s00702-002-0791-7 contributor: fullname: MT Silva – volume: 503 start-page: 103 year: 2004 ident: 298_CR12 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2004.09.042 contributor: fullname: D Klamer – volume: 14 start-page: 243 year: 1993 ident: 298_CR19 publication-title: Synapse doi: 10.1002/syn.890140307 contributor: fullname: R Spanagel – volume: 151 start-page: 99 year: 2000 ident: 298_CR21 publication-title: Psychopharmacol doi: 10.1007/s002130000493 contributor: fullname: LJMJ Vanderschuren – volume: 4 start-page: 199 year: 1982 ident: 298_CR9 publication-title: Neurochem Int doi: 10.1016/0197-0186(82)90055-9 contributor: fullname: U Havemann – volume: 151 start-page: 273 year: 2000 ident: 298_CR3 publication-title: Psychopharmacol doi: 10.1007/s002130000447 contributor: fullname: A Badiani – volume: 499 start-page: 108 year: 1989 ident: 298_CR22 publication-title: Brain Res doi: 10.1016/0006-8993(89)91140-2 contributor: fullname: P Vezina – volume: 16 start-page: 137 year: 1994 ident: 298_CR10 publication-title: Synapse doi: 10.1002/syn.890160207 contributor: fullname: M Jeziorski – volume: 109 start-page: 267 year: 2002 ident: 298_CR17 publication-title: Neuroscience doi: 10.1016/S0306-4522(01)00483-3 contributor: fullname: S Scheggi – volume: 14 start-page: 7415 year: 1994 ident: 298_CR4 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.14-12-07415.1994 contributor: fullname: DM Bannerman – volume: 458 start-page: 119 year: 2003 ident: 298_CR6 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(02)02696-1 contributor: fullname: A Gholami – ident: 298_CR15 – volume: 28 start-page: 755 year: 1981 ident: 298_CR16 publication-title: Life Sci doi: 10.1016/0024-3205(81)90157-0 contributor: fullname: RM Post – volume: 362 start-page: 232 year: 2000 ident: 298_CR1 publication-title: Naunyn Schmiedebergs Arch Pharmacol doi: 10.1007/s002100000287 contributor: fullname: I Afanas’ev – volume: 44 start-page: 227 year: 2002 ident: 298_CR23 publication-title: Synapse doi: 10.1002/syn.10076 contributor: fullname: AR West – volume: 482 start-page: 205 year: 2003 ident: 298_CR25 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2003.10.006 contributor: fullname: MR Zarrindast – volume: 74 start-page: 441 year: 2001 ident: 298_CR14 publication-title: Physiol Behav doi: 10.1016/S0031-9384(01)00588-1 contributor: fullname: K Park – volume: 449 start-page: 269 year: 2002 ident: 298_CR5 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(02)02038-1 contributor: fullname: A Gholami – volume: 54 start-page: 679 year: 1998 ident: 298_CR24 publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(97)00090-7 contributor: fullname: ME Wolf – volume: 14 start-page: 611 year: 1975 ident: 298_CR2 publication-title: Neuropharmacol doi: 10.1016/0028-3908(75)90129-X contributor: fullname: M Babbini – volume: 355 start-page: 531 year: 1997 ident: 298_CR13 publication-title: Naunyn Schmiedebergs Arch Pharmacol doi: 10.1007/PL00004979 contributor: fullname: A-K Lienau – volume: 369 start-page: 228 year: 2004 ident: 298_CR7 publication-title: Naunyn Schmiedebergs Arch Pharmacol doi: 10.1007/s00210-003-0855-8 contributor: fullname: M Grönig – volume: 7 start-page: 169 year: 1996 ident: 298_CR20 publication-title: Behav Pharmacol contributor: fullname: TM Tzschentke – volume: 75 start-page: 881 year: 1996 ident: 298_CR8 publication-title: Neuroscience doi: 10.1016/0306-4522(96)00313-2 contributor: fullname: H Hara – volume: 5 start-page: 48 year: 1990 ident: 298_CR11 publication-title: Synapse doi: 10.1002/syn.890050104 contributor: fullname: PW Kalivas |
SSID | ssj0001178 ssj0053170 ssj0053176 |
Score | 1.9266286 |
Snippet | The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1 |
SubjectTerms | Animals Conditioning, Operant - drug effects Conditioning, Operant - physiology Dose-Response Relationship, Drug Excitatory Amino Acid Antagonists - pharmacology Male Morphine - pharmacology Motor Activity - drug effects Motor Activity - physiology NG-Nitroarginine Methyl Ester - pharmacology Nitric Oxide Synthase - antagonists & inhibitors Nitric Oxide Synthase - physiology Rats Rats, Wistar Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors Receptors, N-Methyl-D-Aspartate - physiology |
Title | Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15843868 https://www.proquest.com/docview/217839154 https://search.proquest.com/docview/19277244 https://search.proquest.com/docview/67588275 |
Volume | 113 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9sILAsaljIsfEA9UrhInTdLHCgoT07qXTRpPkR07TEJLpiVF234aEv-Nc2zntlHEeIlSx3VdnS_n4vP5mJC3SZhHWeD7LFeYZpxxyRKehQwmrYTOI8VNuaaDVbR3HH45mZ2MRr96rKV1LafZ9R_3lfyPVKEN5Iq7ZO8g2XZQaIB7kC9cQcJw_ScZLzsyhgSj9F0oswLwDX5TgCeqJ6uDj4sJ6DR9bg7VKU1KYHWIdQrqU4HL-JblqDrq0MTRDvWlo8gaf1I0UvyBB0FNirJg_aYKafC129KJ7izMBml-yNDMmgPU0NM9K0GuTSr_tk-MpUKwYAAaUABg1SMJLGpc8jeqbNrlnyqkgrr13_3pxiUMt3XL8xgEanZlQVtNDH4cAzUeDFS13bc6wKRVvH7Pglue7C3bYOkgFRY44gwLsGL1eeZ1hrBJ_t-wjy1rsa3wbIZIYYgUh0i9e2Sbg54DBbu9-Px1f9m6Ar4ftzktUHaoGrsPNo3u_nmTcPdMfdvhDIcu04Y4yPhDRw_JAyc0urCofERGunhMdhaFqMuzK_qOGmqxydnskJ8OqLTMaQNUvG-BShGotAUqLS_w8eqQNkClZUEBlbQHVOyETR1Q8Ts9VGKHG0ClA6DSuqQtUGkHVCqvaAPUJ-T40_Lowx5zh4awLJjFNZNxoD0R5xCqSxlCcB5JBT6qnqu5p8PIE1keKzlHyyO5ijOVadBHSTaPecRzrYOnZAvmpp8TGmotZl6kwzyBqCEQMHScRx6PFZ7Np_iYvG_kkp7b2jDpRoyMyW4judSpkCrlgA88oSEckzftU3i9MGknCl2uqxQiMAiAw7_0wJA_4fFsTJ5ZQHSTgegiSKLkxV0mukvud-_oS7JVX6z1K3C8a_nawfs3HyrcZA |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+blockade+of+glutamate+NMDA+receptors+or+of+NO+synthase+on+the+development+or+the+expression+of+associative+or+non-associative+sensitization+to+locomotor+activation+by+morphine&rft.jtitle=Journal+of+Neural+Transmission&rft.au=Atalla%2C+A.&rft.au=Kuschinsky%2C+K.&rft.date=2006-01-01&rft.issn=0300-9564&rft.eissn=1435-1463&rft.volume=113&rft.issue=1&rft.spage=1&rft.epage=10&rft_id=info:doi/10.1007%2Fs00702-005-0298-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00702_005_0298_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9564&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9564&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9564&client=summon |